Friday, May 8, 2020

Neurology/Neuroscience Research Seminar - Presented Virtually by Samuel Terman, MD, MS, Clinical Lecturer/Research Fellow, Department of Neurology, University of Michigan - Friday, May 8th, 2020

12:00 PM to 1:00 PM

One tap mobile
+13126266799,,91045507427# US (Chicago)
+16465588656,,91045507427# US (New York)

Dial by your location
+1 312 626 6799 US (Chicago)
+1 646 558 8656 US (New York)
Find your local number: https://umich-health.zoom.us/u/aBNvz3Xdi

Join by SIP
91045507427@zoomcrc.com

Join by H.323
162.255.37.11 (US West)
162.255.36.11 (US East)

The University of Michigan Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Michigan Medical School designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 
Scan the QR code to register your attendance.

*For iOS devices: Open the phone's camera app and hover over the code. When the notification box appears, tap on it to open the credit claiming screen.
For Android Devices: A QR reader is required. Visit the Google Play store to download a QR app of your choice. Follow the scanning directions provided by the app.

* Please Note: Attendance must be registered within 6 months to be awarded credit. To complete an evaluation for this session, please login to MiCME and go to the Claim Credits & Print Transcripts page.

Join us for:

"Polypharmacy in epilepsy"

Polypharmacy in epilepsy

Polypharmacy is common in patients with epilepsy. Patients taking antiepileptic drugs (AEDs) frequently reported also taking other CNS-acting medications (i.e. opioids, benzodiazepines, and seizure threshold-lowering medications). CNS polypharmacy poses health risks. Future research is needed to explore drivers of polypharmacy and strategies to help mitigate potentially harmful prescription use in this high-risk population.